Vanguard Health Care ETF (VHT) Holdings
VHT holdings summary
as of Oct 25, 2026- Holdings
- 406 positions listed
- Top 10 weight
- 51.9% of net assets
- Effective holdings
- 24 equal-weight equivalent
- Largest holding
- LLY 13.26% Eli Lilly and Company
- Annual turnover
- 3.9% of the portfolio traded
Top 1051.9%
Top 2571.8%
Top 5084.5%
Top 10092.7%
Top 25098.2%
All VHT holdings
406 holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 13.26% | $2.66B | $1.12T | 42.2 |
| 2 | JNJ | Johnson & Johnson | Healthcare | 8.95% | $1.79B | $615.87B | 38.8 |
| 3 | ABBV | AbbVie Inc. | Healthcare | 6.43% | $1.29B | $504.37B | 80.6 |
| 4 | MRK | Merck & Co., Inc. | Healthcare | 4.76% | $954.2M | $360.08B | 115.8 |
| 5 | UNH | UnitedHealth Group Incorporated | Healthcare | 4.68% | $937.9M | $360.32B | 25.8 |
| 6 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 3.55% | $711.9M | $255.13B | 37.1 |
| 7 | AMGN | Amgen Inc. | Healthcare | 3.18% | $636.2M | $233.82B | 26.9 |
| 8 | GILD | Gilead Sciences, Inc. | Healthcare | 2.57% | $515.2M | $193.67B | — |
| 9 | ABT | Abbott Laboratories | Healthcare | 2.37% | $474.9M | $181.50B | 33.8 |
| 10 | PFE | Pfizer Inc. | Healthcare | 2.18% | $436.1M | $168.60B | 38.9 |
| 11 | ISRG | Intuitive Surgical, Inc. | Healthcare | 1.92% | $384.3M | $150.74B | 48.9 |
| 12 | DHR | Danaher Corporation | Healthcare | 1.91% | $381.6M | $161.01B | 40.8 |
| 13 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.80% | $360.2M | $122.05B | 13.2 |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.76% | $353.4M | $126.66B | 28.9 |
| 15 | MDT | Medtronic plc | Healthcare | 1.55% | $310.3M | $121.20B | 23.3 |
| 16 | CVS | CVS Health Corporation | Healthcare | 1.49% | $298.2M | $118.13B | 24.3 |
| 17 | MCK | McKesson Corporation | Healthcare | 1.38% | $276.2M | $117.15B | 26.9 |
| 18 | SYK | Stryker Corporation | Healthcare | 1.28% | $255.9M | $113.02B | 30.5 |
| 19 | ELV | Elevance Health Inc. | Healthcare | 1.14% | $228.9M | $92.88B | 19.0 |
| 20 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 1.04% | $209.2M | $81.41B | 19.6 |
| 21 | CI | Cigna Corporation | Healthcare | 1.00% | $200.7M | $79.88B | 12.5 |
| 22 | HCA | HCA Healthcare, Inc. | Healthcare | 0.97% | $193.9M | $99.34B | 15.4 |
| 23 | BSX | Boston Scientific Corporation | Healthcare | 0.92% | $183.4M | $64.33B | 18.0 |
| 24 | MRNA | Moderna, Inc. | Healthcare | 0.88% | $176.2M | $87.04B | — |
| 25 | NTRA | Natera, Inc. | Healthcare | 0.79% | $157.6M | $56.71B | — |
| 26 | COR | Cencora | Healthcare | 0.76% | $153.0M | $65.06B | 25.3 |
| 27 | CAH | Cardinal Health, Inc. | Healthcare | 0.71% | $141.3M | $58.83B | 35.1 |
| 28 | A | Agilent Technologies, Inc. | Healthcare | 0.69% | $139.0M | $48.77B | 34.1 |
| 29 | EW | Edwards Lifesciences Corporation | Healthcare | 0.67% | $134.8M | $49.92B | 51.5 |
| 30 | BDX | Becton, Dickinson and Company | Healthcare | 0.67% | $134.8M | $52.23B | 44.6 |
| 31 | HUM | Humana Inc. | Healthcare | 0.65% | $129.5M | $49.61B | 39.1 |
| 32 | IQV | IQVIA Holdings Inc. | Healthcare | 0.62% | $125.2M | $43.93B | 33.2 |
| 33 | WAT | Waters Corporation | Healthcare | 0.60% | $120.2M | $42.90B | 110.6 |
| 34 | VEEV | Veeva Systems Inc. | Healthcare | 0.59% | $117.8M | $50.25B | 50.9 |
| 35 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 0.57% | $113.2M | $44.20B | 39.8 |
| 36 | ILMN | Illumina, Inc. | Healthcare | 0.54% | $107.4M | $39.64B | 49.0 |
| 37 | BIIB | Biogen Inc. | Healthcare | 0.49% | $97.7M | $34.37B | 41.3 |
| 38 | DXCM | DexCom, Inc. | Healthcare | 0.48% | $97.1M | $32.47B | 34.1 |
| 39 | RVMD | Revolution Medicines, Inc. | Healthcare | 0.47% | $93.2M | $38.14B | — |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 0.45% | $90.4M | $31.02B | 39.1 |
| 41 | RMD | ResMed Inc. | Healthcare | 0.44% | $89.0M | $33.61B | 22.9 |
| 42 | MTD | Mettler-Toledo International Inc. | Healthcare | 0.43% | $86.7M | $32.51B | 36.6 |
| 43 | CNC | Centene Corporation | Healthcare | 0.41% | $81.6M | $34.16B | — |
| 44 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.40% | $79.6M | $31.42B | 16.0 |
| 45 | ZTS | Zoetis Inc. | Healthcare | 0.39% | $77.9M | $32.80B | 13.1 |
| 46 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.38% | $76.8M | $27.03B | 49.4 |
| 47 | INSM | Insmed Incorporated | Healthcare | 0.35% | $69.9M | $21.02B | — |
| 48 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.34% | $68.8M | $25.94B | 24.6 |
| 49 | LH | Laboratory Corporation of America Holdings | Healthcare | 0.34% | $68.4M | $25.79B | 26.3 |
| 50 | VTRS | Viatris Inc. | Healthcare | 0.30% | $60.1M | $21.43B | — |
| 51 | INCY | Incyte Corporation | Healthcare | 0.30% | $60.1M | $22.92B | 14.4 |
| 52 | THC | Tenet Healthcare Corporation | Healthcare | 0.29% | $59.0M | $21.52B | 10.5 |
| 53 | GH | Guardant Health, Inc. | Healthcare | 0.29% | $58.3M | $21.28B | — |
| 54 | UTHR | United Therapeutics Corporation | Healthcare | 0.29% | $57.3M | $22.87B | 19.1 |
| 55 | STE | STERIS plc | Healthcare | 0.28% | $55.3M | $21.71B | 27.2 |
| 56 | ROIV | Roivant Sciences Ltd. | Healthcare | 0.27% | $54.6M | $24.22B | — |
| 57 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.24% | $48.0M | $18.12B | 23.1 |
| 58 | RVTY | Revvity, Inc. | Healthcare | 0.24% | $47.6M | $17.03B | 73.0 |
| 59 | MEDP | Medpace Holdings, Inc. | Healthcare | 0.21% | $41.2M | $17.26B | 36.3 |
| 60 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.20% | $40.8M | $14.46B | — |
| 61 | EXEL | Exelixis, Inc. | Healthcare | 0.19% | $39.0M | $15.42B | 19.6 |
| 62 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 0.19% | $38.9M | $13.79B | 19.9 |
| 63 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | 0.19% | $38.7M | $13.65B | 14.4 |
| 64 | MDLN | Medline Inc. | Healthcare | 0.19% | $37.7M | $48.38B | 89.9 |
| 65 | SOLV | Solventum Corporation | Healthcare | 0.18% | $36.1M | $14.61B | 10.5 |
| 66 | HALO | Halozyme Therapeutics, Inc. | Healthcare | 0.18% | $35.1M | $13.83B | 35.6 |
| 67 | EHC | Encompass Health Corporation | Healthcare | 0.17% | $34.5M | $12.61B | 21.4 |
| 68 | BAX | Baxter International Inc. | Healthcare | 0.17% | $34.1M | $13.07B | — |
| 69 | TECH | Bio-Techne Corporation | Healthcare | 0.16% | $32.8M | $11.38B | 62.6 |
| 70 | ELAN | Elanco Animal Health Incorporated | Healthcare | 0.16% | $32.5M | $11.76B | — |
| 71 | PEN | Penumbra, Inc. | Healthcare | 0.16% | $31.8M | $12.64B | 78.8 |
| 72 | COO | The Cooper Companies, Inc. | Healthcare | 0.16% | $31.3M | $11.02B | 19.9 |
| 73 | CORT | Corcept Therapeutics Incorporated | Healthcare | 0.16% | $31.2M | $11.91B | 244.8 |
| 74 | TWST | Twist Bioscience Corporation | Healthcare | 0.16% | $31.2M | $8.80B | — |
| 75 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 0.15% | $30.4M | $10.58B | 147.8 |
| 76 | ALGN | Align Technology, Inc. | Healthcare | 0.14% | $29.0M | $10.46B | 25.6 |
| 77 | RGEN | Repligen Corporation | Healthcare | 0.14% | $28.7M | $11.14B | 240.3 |
| 78 | AVTR | Avantor, Inc. | Healthcare | 0.14% | $28.6M | $11.11B | — |
| 79 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 0.14% | $28.6M | $12.98B | — |
| 80 | MOH | Molina Healthcare, Inc. | Healthcare | 0.14% | $28.3M | $10.82B | — |
| 81 | ENSG | The Ensign Group, Inc. | Healthcare | 0.14% | $28.2M | $10.29B | 27.7 |
| 82 | TXG | 10x Genomics, Inc. | Healthcare | 0.14% | $27.0M | $9.10B | — |
| 83 | GKOS | Glaukos Corporation | Healthcare | 0.13% | $25.6M | $9.72B | — |
| 84 | BTSG | BrightSpring Health Services, Inc. | Healthcare | 0.13% | $25.6M | $12.04B | 53.9 |
| 85 | UHS | Universal Health Services, Inc. | Healthcare | 0.12% | $24.8M | $10.91B | 7.6 |
| 86 | PODD | Insulet Corporation | Healthcare | 0.12% | $24.5M | $9.79B | 26.4 |
| 87 | GMED | Globus Medical, Inc. | Healthcare | 0.12% | $23.5M | $10.30B | 19.7 |
| 88 | HSIC | Henry Schein, Inc. | Healthcare | 0.11% | $23.0M | $9.63B | 25.2 |
| 89 | TEM | Tempus AI, Inc. | Healthcare | 0.11% | $22.9M | $11.68B | — |
| 90 | CYTK | Cytokinetics, Incorporated | Healthcare | 0.11% | $22.8M | $8.61B | — |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | Healthcare | 0.11% | $21.7M | $10.39B | — |
| 92 | TGTX | TG Therapeutics, Inc. | Healthcare | 0.11% | $21.4M | $8.26B | 19.6 |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 0.11% | $21.4M | $7.90B | — |
| 94 | HQY | HealthEquity, Inc. | Healthcare | 0.10% | $20.9M | $7.61B | 33.2 |
| 95 | AXSM | Axsome Therapeutics, Inc. | Healthcare | 0.10% | $20.3M | $8.23B | — |
| 96 | BRKR | Bruker Corporation | Healthcare | 0.10% | $20.0M | $8.35B | — |
| 97 | PCVX | Vaxcyte, Inc. | Healthcare | 0.10% | $19.9M | $10.01B | — |
| 98 | KRYS | Krystal Biotech, Inc. | Healthcare | 0.10% | $19.9M | $9.37B | 39.7 |
| 99 | PTGX | Protagonist Therapeutics, Inc. | Healthcare | 0.10% | $19.5M | $8.33B | 125.0 |
| 100 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 0.10% | $19.4M | $7.14B | — |
| 101 | BIO | Bio-Rad Laboratories, Inc. | Healthcare | 0.09% | $19.0M | $9.46B | 44.8 |
| 102 | LNTH | Lantheus Holdings, Inc. | Healthcare | 0.09% | $18.9M | $6.51B | 24.1 |
| 103 | CHE | Chemed Corporation | Healthcare | 0.09% | $18.8M | $6.70B | 25.8 |
| 104 | ALKS | Alkermes plc | Healthcare | 0.09% | $18.7M | $6.92B | 108.5 |
| 105 | PRAX | Praxis Precision Medicines, Inc. | Healthcare | 0.09% | $17.9M | $6.75B | — |
| 106 | LGND | Ligand Pharmaceuticals Incorporated | Healthcare | 0.09% | $17.5M | $5.89B | 31.1 |
| 107 | HIMS | Hims & Hers Health, Inc. | Healthcare | 0.09% | $17.5M | $6.55B | — |
| 108 | KYMR | Kymera Therapeutics, Inc. | Healthcare | 0.08% | $16.6M | $8.62B | — |
| 109 | DVA | DaVita Inc. | Healthcare | 0.08% | $16.3M | $11.95B | 15.8 |
| 110 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 0.08% | $15.9M | $6.17B | — |
| 111 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 0.07% | $15.0M | $7.47B | — |
| 112 | TFX | Teleflex Incorporated | Healthcare | 0.07% | $14.8M | $5.53B | — |
| 113 | MMSI | Merit Medical Systems, Inc. | Healthcare | 0.07% | $14.6M | $5.33B | 36.7 |
| 114 | GRAL | GRAIL, Inc. | Healthcare | 0.07% | $14.5M | $5.26B | — |
| 115 | SHC | Sotera Health Company | Healthcare | 0.07% | $14.5M | $5.11B | 31.4 |
| 116 | RYTM | Rhythm Pharmaceuticals, Inc. | Healthcare | 0.07% | $14.3M | $5.91B | — |
| 117 | TVTX | Travere Therapeutics, Inc. | Healthcare | 0.07% | $13.8M | $4.61B | — |
| 118 | RDNT | RadNet, Inc. | Healthcare | 0.07% | $13.4M | $5.41B | — |
| 119 | PTCT | PTC Therapeutics, Inc. | Healthcare | 0.07% | $13.4M | $4.94B | — |
| 120 | HAE | Haemonetics Corporation | Healthcare | 0.06% | $12.9M | $5.38B | 57.1 |
| 121 | COGT | Cogent Biosciences, Inc. | Healthcare | 0.06% | $12.2M | $5.12B | — |
| 122 | DFTX | Definium Therapeutics, Inc. | Healthcare | 0.06% | $12.1M | $4.31B | — |
| 123 | LIVN | LivaNova PLC | Healthcare | 0.06% | $12.1M | $4.26B | 23.0 |
| 124 | ITGR | Integer Holdings Corporation | Healthcare | 0.06% | $12.1M | $4.31B | 34.6 |
| 125 | HNGE | Hinge Health, Inc. | Healthcare | 0.06% | $12.0M | $8.00B | 32.7 |
| 126 | CON | Concentra Group Holdings Parent, Inc. | Healthcare | 0.06% | $11.6M | $4.91B | 24.9 |
| 127 | SRRK | Scholar Rock Holding Corporation | Healthcare | 0.05% | $10.9M | $4.86B | — |
| 128 | IRTC | iRhythm Technologies, Inc. | Healthcare | 0.05% | $10.5M | $3.58B | — |
| 129 | INDV | Indivior PLC | Healthcare | 0.05% | $10.4M | $3.83B | 11.6 |
| 130 | VCYT | Veracyte, Inc. | Healthcare | 0.05% | $10.4M | $3.47B | 30.8 |
| 131 | NVST | Envista Holdings Corporation | Healthcare | 0.05% | $10.4M | $3.68B | 39.5 |
| 132 | ICUI | ICU Medical, Inc. | Healthcare | 0.05% | $10.3M | $4.08B | 137.0 |
| 133 | MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | 0.05% | $10.3M | $5.20B | — |
| 134 | DOCS | Doximity, Inc. | Healthcare | 0.05% | $9.8M | $5.52B | 36.4 |
| 135 | OGN | Organon & Co. | Healthcare | 0.05% | $9.8M | $3.61B | 17.6 |
| 136 | VKTX | Viking Therapeutics, Inc. | Healthcare | 0.05% | $9.8M | $3.20B | — |
| 137 | HTFL | Heartflow, Inc. | Healthcare | 0.05% | $9.8M | $4.20B | — |
| 138 | ADPT | Adaptive Biotechnologies Corporation | Healthcare | 0.05% | $9.6M | $3.83B | — |
| 139 | CGON | CG Oncology, Inc. | Healthcare | 0.05% | $9.5M | $5.31B | — |
| 140 | NK | NantKwest Inc | Healthcare | 0.05% | $9.5M | — | — |
| 141 | OPCH | Option Care Health, Inc. | Healthcare | 0.04% | $9.0M | $4.67B | 23.6 |
| 142 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 0.04% | $8.9M | $4.03B | — |
| 143 | IDYA | IDEAYA Biosciences, Inc. | Healthcare | 0.04% | $8.9M | $3.17B | — |
| 144 | KOD | Kodiak Sciences Inc. | Healthcare | 0.04% | $8.7M | $5.39B | — |
| 145 | AMRX | Amneal Pharmaceuticals, Inc. | Healthcare | 0.04% | $8.6M | $6.68B | 39.1 |
| 146 | WAY | Waystar Holding Corp. | Healthcare | 0.04% | $8.6M | $5.25B | 39.1 |
| 147 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 0.04% | $8.5M | $4.76B | — |
| 148 | ARQT | Arcutis Biotherapeutics, Inc. | Healthcare | 0.04% | $8.4M | $3.62B | 131.0 |
| 149 | ATRC | AtriCure, Inc. | Healthcare | 0.04% | $7.8M | $2.85B | 267.0 |
| 150 | ERAS | Erasca, Inc. | Healthcare | 0.04% | $7.8M | $4.68B | — |
| 151 | CDNA | CareDx, Inc | Healthcare | 0.04% | $7.7M | $3.31B | 30.8 |
| 152 | NEOG | Neogen Corporation | Healthcare | 0.04% | $7.7M | $2.58B | — |
| 153 | KNSA | Kiniksa Pharmaceuticals, Ltd. | Healthcare | 0.04% | $7.6M | $6.13B | 79.4 |
| 154 | DNLI | Denali Therapeutics Inc. | Healthcare | 0.04% | $7.6M | $2.81B | — |
| 155 | LFST | LifeStance Health Group, Inc. | Healthcare | 0.04% | $7.5M | $4.46B | 90.3 |
| 156 | TMDX | TransMedics Group, Inc. | Healthcare | 0.04% | $7.4M | $2.45B | 18.3 |
| 157 | NHC | National HealthCare Corporation | Healthcare | 0.04% | $7.4M | $3.80B | 27.0 |
| 158 | AMLX | Amylyx Pharmaceuticals, Inc. | Healthcare | 0.04% | $7.2M | $3.31B | — |
| 159 | SUPN | Supernus Pharmaceuticals, Inc. | Healthcare | 0.03% | $6.8M | $2.21B | — |
| 160 | SLS | SELLAS Life Sciences Group, Inc. | Healthcare | 0.03% | $6.7M | $2.02B | — |
| 161 | NEO | NeoGenomics, Inc. | Healthcare | 0.03% | $6.7M | $2.14B | — |
| 162 | SMMT | Summit Therapeutics Inc. | Healthcare | 0.03% | $6.5M | $11.67B | — |
| 163 | CLDX | Celldex Therapeutics, Inc. | Healthcare | 0.03% | $6.5M | $2.16B | — |
| 164 | DYN | Dyne Therapeutics, Inc. | Healthcare | 0.03% | $6.5M | $2.66B | — |
| 165 | TARS | Tarsus Pharmaceuticals, Inc. | Healthcare | 0.03% | $6.5M | $3.19B | — |
| 166 | ACHC | Acadia Healthcare Company, Inc. | Healthcare | 0.03% | $6.5M | $2.79B | — |
| 167 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 0.03% | $6.5M | $2.73B | — |
| 168 | ADMA | ADMA Biologics, Inc. | Healthcare | 0.03% | $6.5M | $2.39B | 15.3 |
| 169 | UFPT | UFP Technologies, Inc. | Healthcare | 0.03% | $6.4M | $2.26B | 31.5 |
| 170 | BCTG | BCTG Acquisition Corp | Financial Services | 0.03% | $6.4M | — | — |
| 171 | BKD | Brookdale Senior Living Inc. | Healthcare | 0.03% | $6.4M | $2.41B | — |
| 172 | RLAY | Relay Therapeutics, Inc. | Healthcare | 0.03% | $6.3M | $3.57B | — |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | 0.03% | $6.3M | $3.29B | 8.6 |
| 174 | CRVL | CorVel Corporation | Financial Services | 0.03% | $6.1M | $4.03B | 35.6 |
| 175 | IMVT | Immunovant, Inc. | Healthcare | 0.03% | $6.1M | $5.52B | — |
| 176 | BEAM | Beam Therapeutics Inc. | Healthcare | 0.03% | $6.0M | $2.42B | — |
| 177 | PBH | Prestige Consumer Healthcare Inc. | Healthcare | 0.03% | $6.0M | $2.36B | 14.0 |
| 178 | MD | Pediatrix Medical Group, Inc. | Healthcare | 0.03% | $5.9M | $2.22B | 13.1 |
| 179 | RCUS | Arcus Biosciences, Inc. | Healthcare | 0.03% | $5.9M | $2.82B | — |
| 180 | LQDA | Liquidia Corporation | Healthcare | 0.03% | $5.9M | $3.07B | 24.7 |
| 181 | IMNM | Immunome, Inc. | Healthcare | 0.03% | $5.8M | $1.94B | — |
| 182 | AXGN | AxoGen, Inc. | Healthcare | 0.03% | $5.8M | $2.03B | — |
| 183 | EWTX | Edgewise Therapeutics, Inc. | Healthcare | 0.03% | $5.8M | $4.04B | — |
| 184 | RXRX | Recursion Pharmaceuticals, Inc. | Healthcare | 0.03% | $5.7M | $1.86B | — |
| 185 | VCEL | Vericel Corporation | Healthcare | 0.03% | $5.7M | $2.05B | 85.4 |
| 186 | PRVA | Privia Health Group, Inc. | Healthcare | 0.03% | $5.6M | $2.88B | 107.2 |
| 187 | HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | 0.03% | $5.5M | $2.21B | 12.2 |
| 188 | PRGO | Perrigo Company plc | Healthcare | 0.03% | $5.4M | $2.30B | — |
| 189 | CELC | Celcuity Inc. | Healthcare | 0.03% | $5.4M | $2.77B | — |
| 190 | ADUS | Addus HomeCare Corporation | Healthcare | 0.03% | $5.3M | $2.17B | 20.3 |
| 191 | SDGR | Schrödinger, Inc. | Healthcare | 0.03% | $5.3M | $1.69B | — |
| 192 | AGIO | Agios Pharmaceuticals, Inc. | Healthcare | 0.03% | $5.2M | $1.87B | — |
| 193 | FTRE | Fortrea Holdings Inc. | Healthcare | 0.03% | $5.1M | $2.14B | — |
| 194 | PGNY | Progyny, Inc. | Healthcare | 0.03% | $5.0M | $2.06B | 29.2 |
| 195 | PACS | PACS Group, Inc. | Healthcare | 0.03% | $5.0M | $7.43B | 27.4 |
| 196 | PGEN | Precigen, Inc. | Healthcare | 0.02% | $4.9M | $2.28B | — |
| 197 | AUP | Aurinia Pharmaceuticals Inc | Technology | 0.02% | $4.9M | — | — |
| 198 | LMAT | LeMaitre Vascular, Inc. | Healthcare | 0.02% | $4.9M | $1.85B | 28.4 |
| 199 | NVCR | NovoCure Limited | Healthcare | 0.02% | $4.9M | $1.64B | — |
| 200 | NKTR | Nektar Therapeutics | Healthcare | 0.02% | $4.8M | $1.22B | — |
| 201 | BHVN | Biohaven Ltd. | Healthcare | 0.02% | $4.8M | $1.63B | — |
| 202 | XRAY | DENTSPLY SIRONA Inc. | Healthcare | 0.02% | $4.8M | $1.71B | — |
| 203 | SRPT | Sarepta Therapeutics, Inc. | Healthcare | 0.02% | $4.8M | $1.81B | — |
| 204 | INSP | Inspire Medical Systems, Inc. | Healthcare | 0.02% | $4.8M | $1.99B | 15.2 |
| 205 | CLOV | Clover Health Investments, Corp. | Healthcare | 0.02% | $4.8M | $2.38B | — |
| 206 | XERS | Xeris Biopharma Holdings, Inc. | Healthcare | 0.02% | $4.7M | $1.88B | — |
| 207 | BFLY | Butterfly Network, Inc. | Healthcare | 0.02% | $4.6M | $1.93B | — |
| 208 | BLFS | BioLife Solutions, Inc. | Healthcare | 0.02% | $4.6M | $1.89B | 39.0 |
| 209 | ALHC | Alignment Healthcare, Inc. | Healthcare | 0.02% | $4.5M | $1.72B | 43.6 |
| 210 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 0.02% | $4.5M | $1.60B | — |
| 211 | URGN | UroGen Pharma Ltd. | Healthcare | 0.02% | $4.5M | $1.69B | — |
| 212 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 0.02% | $4.5M | $2.16B | — |
| 213 | ASTH | Astrana Health, Inc. | Healthcare | 0.02% | $4.5M | $1.83B | 44.3 |
| 214 | KH6_old | KINGHERO | Other | 0.02% | $4.4M | — | — |
| 215 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | 0.02% | $4.4M | $1.99B | — |
| 216 | INVA | Innoviva, Inc. | Healthcare | 0.02% | $4.3M | $1.50B | 4.9 |
| 217 | AZTA | Azenta, Inc. | Healthcare | 0.02% | $4.2M | $1.49B | — |
| 218 | PVLA | Palvella Therapeutics, Inc | Healthcare | 0.02% | $4.2M | $1.73B | — |
| 219 | SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | 0.02% | $4.1M | $1.15B | — |
| 220 | NVAX | Novavax, Inc. | Healthcare | 0.02% | $4.1M | $1.86B | — |
| 221 | VIR | Vir Biotechnology, Inc. | Healthcare | 0.02% | $4.1M | $1.69B | — |
| 222 | AMN | AMN Healthcare Services, Inc. | Healthcare | 0.02% | $4.1M | $1.57B | 15.1 |
| 223 | OMCL | Omnicell, Inc. | Healthcare | 0.02% | $4.1M | $1.61B | 42.1 |
| 224 | MLYS | Mineralys Therapeutics, Inc. | Healthcare | 0.02% | $4.1M | $1.79B | — |
| 225 | NRIX | Nurix Therapeutics, Inc. | Healthcare | 0.02% | $4.0M | $2.67B | 10.0 |
| 226 | VERA | Vera Therapeutics, Inc. | Healthcare | 0.02% | $3.8M | $2.01B | — |
| 227 | CNMD | CONMED Corporation | Healthcare | 0.02% | $3.8M | $1.40B | 25.3 |
| 228 | IRON | Disc Medicine, Inc. | Healthcare | 0.02% | $3.8M | $2.18B | — |
| 229 | TRVI | Trevi Therapeutics, Inc. | Healthcare | 0.02% | $3.8M | $1.69B | — |
| 230 | OMER | Omeros Corporation | Healthcare | 0.02% | $3.8M | $1.17B | 13.3 |
| 231 | NUVB | Nuvation Bio Inc. | Healthcare | 0.02% | $3.7M | $1.56B | — |
| 232 | USPH | U.S. Physical Therapy, Inc. | Healthcare | 0.02% | $3.7M | $1.28B | 476.2 |
| 233 | PNTG | The Pennant Group, Inc. | Healthcare | 0.02% | $3.7M | $1.46B | 46.0 |
| 234 | WGS | GeneDx Holdings Corp. | Healthcare | 0.02% | $3.7M | $1.90B | — |
| 235 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 0.02% | $3.7M | $1.43B | — |
| 236 | ANIP | ANI Pharmaceuticals, Inc. | Healthcare | 0.02% | $3.7M | $1.66B | 15.6 |
| 237 | ATEC | Alphatec Holdings, Inc. | Healthcare | 0.02% | $3.6M | $1.62B | — |
| 238 | MBX | MBX Biosciences, Inc. | Healthcare | 0.02% | $3.6M | $2.39B | — |
| 239 | QURE | uniQure N.V. | Healthcare | 0.02% | $3.5M | $1.51B | — |
| 240 | XNCR | Xencor, Inc. | Healthcare | 0.02% | $3.4M | $1.70B | — |
| 241 | ESTA | Establishment Labs Holdings Inc. | Healthcare | 0.02% | $3.4M | $1.76B | — |
| 242 | GRDN | Guardian Pharmacy Services, Inc. | Healthcare | 0.02% | $3.3M | $2.50B | 38.3 |
| 243 | MNKD | MannKind Corporation | Healthcare | 0.02% | $3.2M | $977.5M | — |
| 244 | OCUL | Ocular Therapeutix, Inc. | Healthcare | 0.02% | $3.2M | $1.51B | — |
| 245 | TNDM | Tandem Diabetes Care, Inc. | Healthcare | 0.02% | $3.2M | $1.13B | — |
| 246 | SGRY | Surgery Partners, Inc. | Healthcare | 0.02% | $3.2M | $1.91B | — |
| 247 | AVAH | Aveanna Healthcare Holdings Inc. | Healthcare | 0.02% | $3.2M | $2.69B | 9.8 |
| 248 | IART | Integra LifeSciences Holdings Corporation | Healthcare | 0.02% | $3.1M | $1.03B | — |
| 249 | ZA8 | ZYMEWORKS DL-00001 | Healthcare | 0.02% | $3.1M | — | — |
| 250 | ENOV | Enovis Corporation | Healthcare | 0.02% | $3.1M | $1.13B | — |
| 251 | PRCT | PROCEPT BioRobotics Corporation | Healthcare | 0.01% | $2.9M | $1.00B | — |
| 252 | TDOC | Teladoc Health, Inc. | Healthcare | 0.01% | $2.8M | $1.03B | — |
| 253 | STOK | Stoke Therapeutics, Inc. | Healthcare | 0.01% | $2.7M | $1.56B | — |
| 254 | CERT | Certara, Inc. | Healthcare | 0.01% | $2.7M | $1.43B | — |
| 255 | RAPP | Rapport Therapeutics, Inc. | Healthcare | 0.01% | $2.7M | $1.32B | — |
| 256 | HROW | Harrow Health, Inc. | Healthcare | 0.01% | $2.6M | $1.02B | — |
| 257 | CSTL | Castle Biosciences, Inc. | Healthcare | 0.01% | $2.6M | $976.4M | — |
| 258 | AORT | Artivion, Inc. | Healthcare | 0.01% | $2.6M | $1.06B | — |
| 259 | PCRX | Pacira BioSciences, Inc. | Healthcare | 0.01% | $2.5M | $1.45B | 103.8 |
| 260 | PSNL | Personalis, Inc. | Healthcare | 0.01% | $2.5M | $1.67B | — |
| 261 | ANAB | AnaptysBio, Inc. | Healthcare | 0.01% | $2.5M | $1.39B | — |
| 262 | TSHA | Taysha Gene Therapies, Inc. | Healthcare | 0.01% | $2.5M | $1.18B | — |
| 263 | CYRX | Cryoport, Inc. | Industrials | 0.01% | $2.4M | $852.9M | — |
| 264 | AMPH | Amphastar Pharmaceuticals, Inc. | Healthcare | 0.01% | $2.4M | $1.10B | 15.3 |
| 265 | AGL | agilon health, inc. | Healthcare | 0.01% | $2.4M | $1.43B | — |
| 266 | RIGL | Rigel Pharmaceuticals, Inc. | Healthcare | 0.01% | $2.4M | $858.7M | 2.7 |
| 267 | PLSE | Pulse Biosciences, Inc. | Healthcare | 0.01% | $2.4M | $3.17B | — |
| 268 | ARDX | Ardelyx, Inc. | Healthcare | 0.01% | $2.4M | $797.8M | — |
| 269 | OMDA | Omada Health, Inc. | Healthcare | 0.01% | $2.3M | $1.08B | 73.5 |
| 270 | TRAX | First Tracks Biotherapeutics | Healthcare | 0.01% | $2.3M | $1.23B | — |
| 271 | SIBN | SI-BONE, Inc. | Healthcare | 0.01% | $2.3M | $872.8M | — |
| 272 | MRVI | Maravai LifeSciences Holdings, Inc. | Healthcare | 0.01% | $2.3M | $2.51B | — |
| 273 | KURA | Kura Oncology, Inc. | Healthcare | 0.01% | $2.3M | $807.8M | — |
| 274 | AVBP | ArriVent BioPharma, Inc. | Healthcare | 0.01% | $2.2M | $821.5M | — |
| 275 | REPL | Replimune Group, Inc. | Healthcare | 0.01% | $2.2M | $1.02B | — |
| 276 | VREX | Varex Imaging Corporation | Healthcare | 0.01% | $2.2M | $781.8M | 34.7 |
| 277 | PAHC | Phibro Animal Health Corporation | Healthcare | 0.01% | $2.1M | $1.58B | 16.0 |
| 278 | JANX | Janux Therapeutics, Inc. | Healthcare | 0.01% | $2.1M | $1.01B | — |
| 279 | ZBIO | Zenas BioPharma, Inc. | Healthcare | 0.01% | $2.0M | $1.62B | — |
| 280 | CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | 0.01% | $2.0M | $800.8M | — |
| 281 | QDEL | QuidelOrtho Corporation | Healthcare | 0.01% | $2.0M | $885.3M | — |
| 282 | IRMD | IRadimed Corporation | Healthcare | 0.01% | $2.0M | $1.13B | 49.3 |
| 283 | HSTM | HealthStream, Inc. | Healthcare | 0.01% | $2.0M | $1.01B | 46.0 |
| 284 | COLL | Collegium Pharmaceutical, Inc. | Healthcare | 0.01% | $2.0M | $755.0M | 18.3 |
| 285 | TKM | Arbutus Biopharma Corp | Other | 0.01% | $1.9M | — | — |
| 286 | MLAB | Mesa Laboratories, Inc. | Technology | 0.01% | $1.9M | $685.4M | 144.1 |
| 287 | INBX | Inhibrx, Inc. | Healthcare | 0.01% | $1.9M | $1.32B | — |
| 288 | TYRA_old | TYRA | Healthcare | 0.01% | $1.9M | — | — |
| 289 | KMTS | Kestra Medical Technologies, Ltd. | Healthcare | 0.01% | $1.9M | $1.62B | — |
| 290 | STAA | STAAR Surgical Company | Healthcare | 0.01% | $1.9M | $1.07B | 265.9 |
| 291 | SEPN | Septerna, Inc. | Healthcare | 0.01% | $1.8M | $1.70B | — |
| 292 | CTKB | Cytek Biosciences, Inc. | Healthcare | 0.01% | $1.8M | $682.4M | — |
| 293 | IRWD | Ironwood Pharmaceuticals, Inc. | Healthcare | 0.01% | $1.8M | $578.3M | 4.5 |
| 294 | MAZE | Maze Therapeutics, Inc. | Healthcare | 0.01% | $1.8M | $1.53B | — |
| 295 | MGTX | MeiraGTx Holdings plc | Healthcare | 0.01% | $1.7M | $891.3M | 10.7 |
| 296 | ORIC | ORIC Pharmaceuticals, Inc. | Healthcare | 0.01% | $1.7M | $1.28B | — |
| 297 | OPK | OPKO Health, Inc. | Healthcare | 0.01% | $1.7M | $1.14B | — |
| 298 | JBIO | Jade Biosciences, Inc. | Healthcare | 0.01% | $1.6M | $856.7M | — |
| 299 | PACB | Pacific Biosciences of California, Inc. | Healthcare | 0.01% | $1.6M | $537.7M | — |
| 300 | BVS | Bioventus Inc. | Healthcare | 0.01% | $1.6M | $908.5M | 17.1 |
| 301 | CGEM | Cullinan Oncology, Inc. | Healthcare | 0.01% | $1.6M | $794.7M | — |
| 302 | GERN | Geron Corporation | Healthcare | 0.01% | $1.6M | $751.7M | — |
| 303 | CBLL | CeriBell, Inc | Healthcare | 0.01% | $1.5M | $961.0M | — |
| 304 | MDXG | MiMedx Group, Inc. | Healthcare | 0.01% | $1.5M | $646.5M | 110.8 |
| 305 | CRMD | CorMedix Inc. | Healthcare | 0.01% | $1.5M | $565.9M | 3.5 |
| 306 | AURA | Aura Biosciences, Inc. | Healthcare | 0.01% | $1.5M | $632.6M | — |
| 307 | BCAX | Bicara Therapeutics Inc. | Healthcare | 0.01% | $1.5M | $1.11B | — |
| 308 | ANGO | AngioDynamics, Inc. | Healthcare | 0.01% | $1.5M | $472.7M | — |
| 309 | GLUE | Monte Rosa Therapeutics, Inc. | Healthcare | 0.01% | $1.5M | $831.0M | — |
| 310 | MLTX_old | Multex Com Inc | Other | 0.01% | $1.5M | — | — |
| 311 | DNA | Ginkgo Bioworks Holdings, Inc. | Healthcare | 0.01% | $1.5M | $691.6M | — |
| 312 | ANNX | Annexon, Inc. | Healthcare | 0.01% | $1.5M | $646.5M | — |
| 313 | PHR | Phreesia, Inc. | Healthcare | 0.01% | $1.5M | $679.1M | 64.4 |
| 314 | SANA | Sana Biotechnology, Inc. | Healthcare | 0.01% | $1.5M | $679.5M | — |
| 315 | AHCO | AdaptHealth Corp. | Healthcare | 0.01% | $1.5M | $803.1M | — |
| 316 | TCMD | Tactile Systems Technology, Inc. | Healthcare | 0.01% | $1.4M | $510.1M | 20.9 |
| 317 | FDMT | 4D Molecular Therapeutics, Inc. | Healthcare | 0.01% | $1.4M | $670.7M | — |
| 318 | STTK | Shattuck Labs, Inc. | Healthcare | 0.01% | $1.4M | $544.0M | — |
| 319 | WVE | Wave Life Sciences Ltd. | Healthcare | 0.01% | $1.4M | $616.8M | — |
| 320 | ACRS | Aclaris Therapeutics, Inc. | Healthcare | 0.01% | $1.4M | $482.8M | — |
| 321 | SVRA | Savara Inc. | Healthcare | 0.01% | $1.4M | $914.3M | — |
| 322 | OLMA | Olema Pharmaceuticals, Inc. | Healthcare | 0.01% | $1.4M | $575.7M | — |
| 323 | TLRY | Tilray Brands, Inc. | Healthcare | 0.01% | $1.4M | $449.3M | — |
| 324 | CTMX | CytomX Therapeutics, Inc. | Healthcare | 0.01% | $1.3M | $496.8M | — |
| 325 | CERS | Cerus Corporation | Healthcare | 0.01% | $1.3M | $439.3M | — |
| 326 | ALT | Altimmune, Inc. | Healthcare | 0.01% | $1.3M | $427.9M | — |
| 327 | CAPR | Capricor Therapeutics, Inc. | Healthcare | 0.01% | $1.3M | $390.1M | — |
| 328 | ALMS | Alumis Inc. | Healthcare | 0.01% | $1.3M | $792.1M | — |
| 329 | VSTM | Verastem, Inc. | Healthcare | 0.01% | $1.2M | $783.4M | — |
| 330 | DFPH | DFP Healthcare Acquisitions Corp | Consumer Defensive | 0.01% | $1.2M | — | — |
| 331 | ARVN | Arvinas, Inc. | Healthcare | 0.01% | $1.2M | $449.7M | 26.8 |
| 332 | VOR | Vor Biopharma Inc. | Healthcare | 0.01% | $1.2M | $977.0M | 0.1 |
| 333 | FLGT | Fulgent Genetics, Inc. | Healthcare | 0.01% | $1.2M | $545.1M | — |
| 334 | ALLO | Allogene Therapeutics, Inc. | Healthcare | 0.01% | $1.2M | $452.6M | — |
| 335 | RGNX | REGENXBIO Inc. | Healthcare | 0.01% | $1.2M | $457.1M | — |
| 336 | LXRX | Lexicon Pharmaceuticals, Inc. | Healthcare | 0.01% | $1.2M | $676.3M | — |
| 337 | OABI | OmniAb, Inc. | Healthcare | 0.01% | $1.1M | $667.3M | — |
| 338 | MYGN | Myriad Genetics, Inc. | Healthcare | 0.01% | $1.1M | $380.7M | — |
| 339 | SLDB | Solid Biosciences Inc. | Healthcare | 0.01% | $1.1M | $593.0M | — |
| 340 | KIDS | OrthoPediatrics Corp. | Healthcare | 0.01% | $1.1M | $573.1M | — |
| 341 | EOLS | Evolus, Inc. | Healthcare | 0.01% | $1.1M | $469.0M | — |
| 342 | EDIT | Editas Medicine, Inc. | Healthcare | 0.01% | $1.1M | $360.9M | — |
| 343 | PHAT | Phathom Pharmaceuticals, Inc. | Healthcare | 0.01% | $1.0M | $559.8M | — |
| 344 | PRTA | Prothena Corporation plc | Healthcare | 0.01% | $1.0M | $428.7M | — |
| 345 | ARCT | Arcturus Therapeutics Holdings Inc. | Healthcare | 0.01% | $1.0M | $293.9M | — |
| 346 | OCGN | Ocugen, Inc. | Healthcare | 0.00% | $981,479.33 | $264.6M | — |
| 347 | CYH | Community Health Systems, Inc. | Healthcare | 0.00% | $961,449.14 | $406.1M | 1.6 |
| 348 | EBS | Emergent BioSolutions Inc. | Healthcare | 0.00% | $961,449.14 | $327.1M | — |
| 349 | EVH | Evolent Health, Inc. | Healthcare | 0.00% | $941,418.95 | $516.7M | — |
| 350 | PRME | Prime Medicine, Inc. | Healthcare | 0.00% | $921,388.76 | $629.4M | — |
| 351 | EMBC | Embecta Corp. | Healthcare | 0.00% | $881,328.38 | $355.3M | 4.3 |
| 352 | SLP | Simulations Plus, Inc. | Healthcare | 0.00% | $881,328.38 | $374.2M | 46.2 |
| 353 | OFIX | Orthofix Medical Inc. | Healthcare | 0.00% | $881,328.38 | $379.2M | — |
| 354 | RLMD | Relmada Therapeutics, Inc. | Healthcare | 0.00% | $841,268.00 | $330.7M | — |
| 355 | CBIO | Crescent Biopharma, Inc. | Healthcare | 0.00% | $821,237.81 | $439.8M | — |
| 356 | GDRX | GoodRx Holdings, Inc. | Healthcare | 0.00% | $801,207.62 | $1.15B | 67.2 |
| 357 | NGNE | Neurogene Inc. | Healthcare | 0.00% | $801,207.62 | $465.3M | — |
| 358 | VNDA | Vanda Pharmaceuticals Inc. | Healthcare | 0.00% | $781,177.43 | $243.7M | — |
| 359 | AVIR | Atea Pharmaceuticals, Inc. | Healthcare | 0.00% | $741,117.05 | $346.5M | — |
| 360 | RZLT | Rezolute, Inc. | Healthcare | 0.00% | $741,117.05 | $346.3M | — |
| 361 | ASMB | Assembly Biosciences, Inc. | Healthcare | 0.00% | $741,117.05 | $409.0M | 19.3 |
| 362 | EYPT | EyePoint Pharmaceuticals, Inc. | Healthcare | 0.00% | $701,056.67 | $250.7M | — |
| 363 | CATX | Perspective Therapeutics, Inc. | Healthcare | 0.00% | $701,056.67 | $247.7M | — |
| 364 | STRO | Sutro Biopharma, Inc. | Healthcare | 0.00% | $660,996.29 | $181.4M | — |
| 365 | OSUR | OraSure Technologies, Inc. | Healthcare | 0.00% | $660,996.29 | $249.0M | — |
| 366 | AKBA | Akebia Therapeutics, Inc. | Healthcare | 0.00% | $660,996.29 | $185.7M | — |
| 367 | RCKT | Rocket Pharmaceuticals, Inc. | Healthcare | 0.00% | $660,996.29 | $239.3M | — |
| 368 | TMCI | Treace Medical Concepts, Inc. | Healthcare | 0.00% | $640,966.10 | $251.7M | — |
| 369 | FATE | Fate Therapeutics, Inc. | Healthcare | 0.00% | $640,966.10 | $214.5M | — |
| 370 | SPRY | ARS Pharmaceuticals, Inc. | Healthcare | 0.00% | $580,875.52 | $399.8M | — |
| 371 | ZNTL | Zentalis Pharmaceuticals, Inc. | Healthcare | 0.00% | $580,875.52 | $209.0M | — |
| 372 | TECX | Tectonic Therapeutic Inc. | Healthcare | 0.00% | $560,845.33 | $403.7M | — |
| 373 | RXST | RxSight, Inc. | Healthcare | 0.00% | $560,845.33 | $187.6M | — |
| 374 | KROS | Keros Therapeutics, Inc. | Healthcare | 0.00% | $540,815.14 | $211.4M | — |
| 375 | LRMR | Larimar Therapeutics, Inc. | Healthcare | 0.00% | $520,784.95 | $206.2M | — |
| 376 | AVXL | Anavex Life Sciences Corp. | Healthcare | 0.00% | $520,784.95 | $121.4M | — |
| 377 | QSI | Quantum-Si incorporated | Healthcare | 0.00% | $500,754.76 | $245.1M | — |
| 378 | FULC | Fulcrum Therapeutics, Inc. | Healthcare | 0.00% | $500,754.76 | $278.8M | — |
| 379 | LMRI | Lumexa Imaging Holdings, Inc. | Healthcare | 0.00% | $480,724.57 | $1.04B | — |
| 380 | FLDM | Fluidigm Corporation | Healthcare | 0.00% | $480,724.57 | — | — |
| 381 | UPB | Upstream Bio, Inc. | Healthcare | 0.00% | $460,694.38 | $151.2M | — |
| 382 | QTRX | Quanterix Corporation | Healthcare | 0.00% | $420,634.00 | $135.7M | — |
| 383 | ALEC | Alector, Inc. | Healthcare | 0.00% | $400,603.81 | $205.4M | — |
| 384 | SIGA | SIGA Technologies, Inc. | Healthcare | 0.00% | $380,573.62 | $227.8M | — |
| 385 | HUMA | Humacyte, Inc. | Healthcare | 0.00% | $380,573.62 | $119.2M | — |
| 386 | TRDA | Entrada Therapeutics, Inc. | Healthcare | 0.00% | $340,513.24 | $170.2M | — |
| 387 | IPSC | Century Therapeutics, Inc. | Healthcare | 0.00% | $300,452.86 | $248.1M | — |
| 388 | CTEV | Claritev Corporation | Healthcare | 0.00% | $300,452.86 | $374.9M | — |
| 389 | MPLT | MapLight Therapeutics, Inc. | Healthcare | 0.00% | $300,452.86 | $427.9M | — |
| 390 | MXCT | MaxCyte Inc | Healthcare | 0.00% | $300,452.86 | — | — |
| 391 | CMPX | Compass Therapeutics, Inc. | Healthcare | 0.00% | $280,422.67 | $154.9M | — |
| 392 | ORGO | Organogenesis Holdings Inc. | Healthcare | 0.00% | $280,422.67 | $128.6M | — |
| 393 | KRRO | Korro Bio, Inc. | Healthcare | 0.00% | $260,392.48 | $125.0M | — |
| 394 | LYEL | Lyell Immunopharma, Inc. | Healthcare | 0.00% | $260,392.48 | $199.0M | — |
| 395 | SION | Sionna Therapeutics, Inc. | Healthcare | 0.00% | $240,362.29 | $175.6M | — |
| 396 | EVMN | Evommune, Inc. | Healthcare | 0.00% | $220,332.10 | $187.6M | — |
| 397 | HCAT | Health Catalyst, Inc. | Healthcare | 0.00% | $220,332.10 | $129.8M | — |
| 398 | LENZ | LENZ Therapeutics, Inc. | Healthcare | 0.00% | $200,301.90 | $102.7M | — |
| 399 | ALDX | Aldeyra Therapeutics, Inc. | Healthcare | 0.00% | $180,271.71 | $42.2M | — |
| 400 | PLRX | Pliant Therapeutics, Inc. | Healthcare | 0.00% | $160,241.52 | $55.7M | — |
| 401 | SAVA | Cassava Sciences Inc | Healthcare | 0.00% | $100,150.95 | — | — |
| 402 | NMRA | Neumora Therapeutics, Inc. | Healthcare | 0.00% | $100,150.95 | $89.0M | — |
| 403 | DCGO | DocGo Inc. | Healthcare | 0.00% | $100,150.95 | $26.9M | — |
| 404 | OMI | Owens & Minor Inc | Healthcare | 0.00% | $100,150.95 | — | — |
| 405 | HRTX | Heron Therapeutics, Inc. | Healthcare | 0.00% | $80,120.76 | $68.5M | — |
| 406 | DH | Definitive Healthcare Corp. | Healthcare | 0.00% | $40,060.38 | $106.7M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($20.03B). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
VHT sector breakdown
| Sector | Weight | Holdings | Largest |
|---|---|---|---|
| Healthcare | 99.1% | 397 | LLY, JNJ, ABBV |
| Financial Services | 0.1% | 2 | BCTG, CRVL |
| Other | 0.0% | 3 | KH6_old, TKM, MLTX_old |
| Technology | 0.0% | 2 | AUP, MLAB |
| Industrials | 0.0% | 1 | CYRX |
| Consumer Defensive | 0.0% | 1 | DFPH |
Sum of the weights of the holdings in each sector.
VHT top industries
Drug Manufacturers - General
43.7%
Diagnostics & Research
11.8%
Biotechnology
10.7%
Medical Devices
9.7%
Healthcare Plans
9.6%
Medical Instruments & Supplies
5.0%
Medical Distribution
3.0%
Medical Care Facilities
2.3%
Drug Manufacturers - Specialty & Generic
2.1%
Health Information Services
1.3%
Shell Companies
0.0%
Insurance Brokers
0.0%
Technical & System Software
0.0%
Integrated Freight & Logistics
0.0%
Scientific & Technical Instruments
0.0%
VHT overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| FHLC | Fidelity MSCI Health Care ETF | 96.2% | 317 of 334 | 0.07% |
| IYH | iShares U.S. Healthcare ETF | 87.2% | 95 of 99 | 0.39% |
| XLV | Health Care Select Sector SPDR Fund | 85.0% | 60 of 60 | 0.09% |
| TRUH | VanEck Healthcare TruSector ETF | 84.9% | 60 of 60 | — |
| IXJ | iShares Global Healthcare ETF | 73.1% | 60 of 106 | 0.42% |
| RXL | ProShares Ultra Health Care | 63.0% | 60 of 61 | 0.93% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the VHT portfolio
Vanguard Health Care ETF holds 406 positions. The ten largest make up 51.9% of the fund and the top 50 84.5%, so it behaves like a portfolio of about 24 equally weighted stocks. The biggest positions are Eli Lilly and Company (13.26%), Johnson & Johnson (8.95%), AbbVie Inc. (6.43%), Merck & Co., Inc. (4.76%), UnitedHealth Group Incorporated (4.68%).
By sector, Healthcare is 99.1%, Financial Services is 0.1%, Other is 0.0%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: VHT chart, VHT performance, VHT dividends, VHT valuation, VHT overview.
VHT holdings FAQ
How many holdings does VHT have?
VHT holds 406 positions as of October 25, 2026.
What are the top 10 holdings of VHT?
The ten largest holdings are Eli Lilly and Company (13.26%), Johnson & Johnson (8.95%), AbbVie Inc. (6.43%), Merck & Co., Inc. (4.76%), UnitedHealth Group Incorporated (4.68%), Thermo Fisher Scientific Inc. (3.55%), Amgen Inc. (3.18%), Gilead Sciences, Inc. (2.57%), Abbott Laboratories (2.37%), Pfizer Inc. (2.18%). Together they are 51.9% of the fund.
What percentage of VHT is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 13.26% of net assets, about $2.66B of the fund's $20.03B.
Which sector is the largest in VHT?
Healthcare is the largest sector at 99.1%, followed by Financial Services (0.1%) and Other (0.0%), based on the sectors of the individual holdings.
How concentrated is VHT?
The top 10 holdings are 51.9% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) VHT behaves like a portfolio of about 24 equally weighted stocks.